成人肺动脉高压影像学:Fleischner学会立场文件
肺动脉高压定义为平均肺动脉压大于20 mmHg,分为五组。Fleischner学会成立工作组,通过系统综述形成立场文件,强调CT、MRI和核医学在肺动脉高压识别、病因确定、严重度评估、慢性血栓栓塞性肺动脉高压治疗前评估及治疗后随访中的关键作用。
要点
- 影像学在肺动脉高压多学科评估中具有核心作用。
- CT、MRI和核医学可用于无创识别肺动脉高压并协助确定病因。
- 影像学用于评估严重度、并发症及慢性血栓栓塞性肺动脉高压治疗前评估。
核心结论
- 影像学在肺动脉高压的识别、检查、治疗规划和随访中起关键作用。
研究设计与样本
- Fleischner学会基于影像学和/或肺动脉高压患者管理专长及系统综述方法学经验成立工作组。
- 工作组通过系统综述形成立场文件。
主要发现
- 工作组确定了关于CT、MRI和核医学在肺动脉高压评估中效用的关键问题。
关键数值与推荐
- 肺动脉高压定义为平均肺动脉压大于20 mmHg。
- 肺动脉高压分为五组,各组共享相似病理生理机制、血流动力学特征和治疗管理。
临床怎么用
- 放射科医生在肺动脉高压多学科评估和管理中扮演关键角色。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Pulmonary hypertension (PH) is defined by a mean pulmonary artery pressure greater than 20 mmHg and classified into five different groups sharing similar pathophysiologic mechanisms, haemodynamic characteristics, and therapeutic management. Radiologists play a key role in the multidisciplinary assessment and management of PH. A working group was formed from within the Fleischner Society based on expertise in the imaging and/or management of patients with PH, as well as experience with methodologies of systematic reviews. The working group identified key questions focusing on the utility of CT, MRI, and nuclear medicine in the evaluation of PH: a) Is noninvasive imaging capable of identifying PH? b) What is the role of imaging in establishing the cause of PH? c) How does imaging determine the severity and complications of PH? d) How should imaging be used to assess chronic thromboembolic PH before treatment? e) Should imaging be performed after treatment of PH? This systematic review and position paper highlights the key role of imaging in the recognition, work-up, treatment planning, and follow-up of PH.
引用
- Remy-Jardin M, Ryerson CJ, Schiebler ML, et al. Imaging of pulmonary hypertension in adults: a position paper from the Fleischner Society. Eur Respir J. 2021. PMID: 33402372. doi:10.1183/13993003.04455-2020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。